Lancet (London, England)HumansChildAsthmaFemaleMale
Budesonide-formoterol versus salbutamol as reliever therapy in children with mild asthma (CARE): a 52-week, open-label, multicentre, superiority, randomised controlled trial.
Lee Hatter, Mark Holliday, Karen Oldfield, Ciléin Kearns, Tasmin Barry, Melissa Black, Pepa Bruce, Atalie Colman, Emily Dickinson, Allie Eathorne, Matire Harwood, Thomas Hills, Rebekah Lamb, Kyley Kerse, Srinidhi Krishnamoorthy
Published: 202510.1016/S0140-6736(25)00861-X
Abstract
BACKGROUND: Combination inhaled corticosteroid-formoterol reliever monotherapy reduces the rate of asthma attacks compared to short-acting β2-agonist (SABA) reliever monotherapy in adults. Its comparative efficacy in children has not been established…
Preview only. Read the full abstract at the source